期刊文献+

缓释镇痛药物的种类及载体材料 被引量:1

Various delayed release analgesic drugs and their carrier materials
下载PDF
导出
摘要 检索Pubmed数据库和中国期刊全文数据库、中国生物医学文献数据库等,对资料进行整理,研究缓释镇痛药物载体材料的特点。结果表明目前此类高分子材料有生物降解型和非生物降解型两大类。生物降解型高分子材料因其能在生物体内经水解、酶解等过程逐渐降解成低分子量化合物或单体,进而能被排出体外或参加体内正常代谢而消耗掉,故而更具有优势,其中聚乳酸及其共聚物就是此类材料的代表品种。聚乳酸及其共聚物在人体内的代谢是通过水解或酶解最终被完全降解为CO2和水,在人体内无积聚问题,且人体对此类材料有很强的耐受性,故成为人们广泛关注的药物缓释高分子材料。 A search of Pubmed database, China Journal Full-text Database and China Bio-Medical Literature on disc was undertaken to investigate the characteristics of carrier material of delayed release analgesic drugs. Results revealed that, the high-polymer materials include bio-degradable ones and non-bio-degradable ones. Bio-degradable high polymer materials, representative as polylactic acid and its copolymer, are predominant due to they can be degraded into low molecular weight compound or monomer by hydrolysis and enzymolysis, leading to their expulsion in vitro or participation in normal metabolism in vivo, which indicate the consumption. Polylactic acid and its copolymer can be completely degraded into CO2 and water through hydrolysis or enzymolysis, so they can not accumulate in the human body, moreover the human body is strongly tolerant to the materials, therefore, polylactic acid and its copolymer have attracted many attentions as a high polymer material for drug delayed release.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2008年第14期2717-2720,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献14

  • 1单军.生物活性高分子材料[J].化工新型材料,1995,23(12):5-7. 被引量:9
  • 2张灿,丁娅,沈健.新型肝靶向载体N-乳糖酰化壳聚糖的制备与表征[J].中国药科大学学报,2003,34(5):387-390. 被引量:20
  • 3Kafedjiiski K, Krauland AH, Hoffer MH, et aI.Synthesis and in vitro evaluation of a novel thiolated chitosan.Biomaterials 2005;26(7):819-826
  • 4Torrado S, Prada E de la Torre PM,et al.Chitosan- poly(acrylic) acid polyionic complex: in vivo study to demonstrate prolonged gastric retention. Biomaterials 2004;25(5):917-923.
  • 5Hofer C , Hartung R , Gobel R , et al. New ultradeform able drug carders for potentialtransderm alapplication of interleukin-2 and interferon-alpha: theoretic and practicalaspects.World J Surg 2000;24(10): 1187-1189.
  • 6郭健新,平其能,黄罗生.柔性环孢素纳米脂质体的制备及其变形性[J].中国药科大学学报,1999,30(3):187-191. 被引量:44
  • 7Cevc G , Gebauer D , Sfieber J, et al. UItraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin.Biochim Biophys Acta 1998; 1368(2):201-215.
  • 8Kim S, Turker MS, Chi EY, et al. Preparation of multivesicular liposomes. Biochim Biophys Acta 1983;728(3):339-348.
  • 9Kim T, Kim J, Kim S. Extended-release formulation of morphine for subcutaneous administration. Cancer Chemother Pharmacol 1993;33(3):187-190.
  • 10Yaksh TL, Provencher JC, Rathbun ML, et al. Safety assessment of encapsulated morphine delivered epidurally in a sustained-release multivesicular liposome preparation in dogs. Drug Deliv 2000;7(1): 27-36.

二级参考文献24

  • 1翁帼英 陈明非.脂质体中卵磷脂的氧化产物与溶血的关系[J].生物化学与生物物理进展,1990,17(1):76-76.
  • 2Ogawara K, Yoshida M, Higaki K, et al.Hepatic uptake of polystyrene microspheres in rats: effect of particle size on intrahepetic distribution[J]. J Control Release,1999,59:15-22.
  • 3Akamatsu K,Imai M,Yamasaki Y, et al.Disposition characteristics of glycosylated poly(amino acids) as liver cell-specific drug carrier[J]. J Drug Target,1998,6: 229-239.
  • 4Moghimi SM,Porter CJH, Muir IS, et al.Non-phagocytic uptake of intravenously injected microspheres in rat spleen: Influence of particle size and hydrophilic coating [ J ]. Biochem Biophys Res Commun, 1991,177 :861-866.
  • 5Regoeczi E, Debanne MT, Hatton MWC, et al.Elimination of asialofetuin and asialoomsomucoid by the intact rat quantitative aspects of the hepatic clearance mechanism[J].Biocim Biophys Acta, 1978,541 : 372-384.
  • 6Ashwell G, Harford J. Carbohydrate-specific receptors of the liver[J]. Ann Rev Biochem , 1982,51:531-554.
  • 7Bridges K,Harford J,Ashwell G, et al. Fate of receptor and ligand during endocytosis of asialoglycoproteins by isolated hepatocytes [ J].Proc Natl Acad Sci, 1982,79:350-354.
  • 8Harford J,Bridges K, Ashwell G, et al. Intracellular dissociation of receptor-bound asialoglycoproteins in cultured hepatocytes [J]. J Biol Chem, 1983,258:3191-3197.
  • 9Fiume L, Busi C,Mattioli A,et al. Hepatocyte targeting of adenine-9-b-D-arabinofuranoside 59-monophosphate (ara-AMP) coupled to lactosaminated albumin [J]. FEBS Lett, 1981,129:261-264.
  • 10Fiume L,Busi C,Mattioli A. Lactosaminated human serum albumin as hepatotropic drug carrier rate of uptake by mouse liver [J]. FEBS Lett, 1982,146:42-46.

共引文献129

同被引文献22

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部